Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients.
Saved in:
| Title: | Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients. |
|---|---|
| Authors: | Azimi P; Department of neurosurgery, Alborz University of medical sciences, Karaj, Iran.; Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Bazrgar M; Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Yazdanian T; Neurological Clinical Research Institute and Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Totonchi M; Faculty Member in Genetics and Stem Cell Departments, Royan Institute, Tehran, Iran., Ahmadiani A; Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. |
| Source: | PloS one [PLoS One] 2025 Jun 12; Vol. 20 (6), pp. e0326054. Date of Electronic Publication: 2025 Jun 12 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0326054 |
